LOS ANGELES, July 11, 2025 /PRNewswire/ -- PepsiCo (NASDAQ: PEP) is saddling up for summer with the launch of an exclusive collaboration with renowned streetwear brand Samii Ryan®. The Pepsi® x Samii Ryan capsule collection is a bold fusion of Y2K nostalgia, rodeo-core fashion, and the unmistakable flavor of PEPSI® Wild Cherry —dropping online on July 11, 2025. Designed to channel the fizzy spirit of summer and the freedom of self-expression, the collection features vintage-inspired denim jackets, graphic t ...

Whimsical, wearable, and trend-right - the collaboration spans Fall 2025 through Spring 2026 and beyond, delivering playful, collectible fashion moments for the modern familySECAUCUS, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- The Children’s Place, Inc. (Nasdaq: PLCE), the largest pure-play children’s specialty retailer in North America with an omni-channel portfolio of brands and an industry-leading digital-first model, today announced a new collaboration with global lifestyle brand, Sanrio®. The multi-season ...

Group 1 - Johnson & Johnson is set to release its second-quarter earnings on July 16, with analysts estimating adjusted earnings of $2.68 per share and sales of $22.85 billion [1] - Investor focus will be on the updated 2025 guidance, the impact of tariffs and biosimilars, and the progress of the company's pipeline and recent product launches [1][3] - Bank of America Securities has updated its revenue estimates for Johnson & Johnson for 2025 and beyond ahead of the earnings release [2] Group 2 - Bank of America slightly increased its second-quarter 2025 revenue and EPS estimates by 1% due to improved foreign exchange rates, with similar modest increases projected for the later 2020s [4] - Despite the upward revisions, Bank of America maintains a Neutral rating and a price forecast of $61, considering the stock fairly valued [5] - Johnson & Johnson anticipates a $2 billion net headwind in 2025, affecting various assets while Xarelto is expected to benefit [6] Group 3 - CFO Joseph Wolk revised the estimated 2025 tariff impact down to $200 million from $400 million, with the majority expected in the second half of the year [7] - A federal court sided with the U.S. Department of Health and Human Services, rejecting Johnson & Johnson's attempt to alter its participation in the 340B Drug Pricing Program [7][8]

Give me fun. Give me rights. Give me fight. Give me nerve. ...

| 招商通知 | | --- | | 第三届全球手术机器人大会 | | 第二届全球医疗科技大会 | 2025年7月1日 ， 专 注胶囊内窥镜技术创新的医疗科技公司 CapsoVision, Inc.（纳斯达克代码：CV） ，宣布其 首次公开募股 （IPO） 定价为每股 5.00 美元，共发行 550 万股普通股，预计募资 约2750万美元（约合人民币2亿） 。 股票于 7 月 2 日在纳斯达克 资本市场开始交易。这次发行不仅是融资事件，更意味着这家专注胃肠道诊断创新的公司，正试图在全球医疗市场中占据更重要的位 置。 CapsoVision 的首席执行官 Dean Burns 在公司发布会上表示："从一开始，我们的目标就是让胶囊内窥镜不仅能看见，更能看全。今 天的 IPO，是让我们更接近这个愿景的重要一步。" # 市 场与竞 争环 境 全球胶囊内窥镜市场预计到 2030 年将达到 12 亿美元。推动这一市场发展的核心动力是人口老龄化、消化道疾病患病率上升，以及人 们对非侵入性检查方式的偏好。特别是在结直肠癌筛查领域，随着人们预防意识增强，非侵入式检测的需求愈加迫切。 然而，CapsoVision 面对的竞争也异 ...

蔚蓝锂芯 20250703 摘要 公司低倍率容量型产品出货量显著增加，2025 年出货量较 2024 年实 现数倍增长，支撑了旧动能的增速，同时公司已成为全球第五家 PBO 供 应商，为未来业绩增长提供重要抓手。 下游客户广泛采用 BBU，尤其是在 GV300 和鲁冰架构中，单个 GPT300 的 PSU 功率约为 5.5 千瓦，Rubin 架构可能达到 8.5 千瓦或 10 千瓦，BBU 瓦数与 PSU 一一对应，推动了 BBU 和 PSU 功率的整体 上升。 英伟达欧姆龙机架约有 48 个 PSU，对应 48 个 BBU，约需 3,500 颗 1,860 电芯（2.5 容量），Rubin 架构或将设计边舱方案以堆积更多算 力及 PSUs 和 BBUs。 电芯定价略有回调，工具市场售价约为三倍。供应链中，CSP 掌握最终 决策权，但电芯厂、pack 厂、电源厂、服务器厂商等共同组成方案建议 权，各环节均需重视。 公司已推出三到四款 BBU 电芯产品，并正在进行验证，计划在未来两到 三年内抓住新一代 BBU 转换契机，扩大市场份额，同时已有两款产品覆 盖 5.5 千瓦领域，另有两款覆盖 8.8 千瓦以上领域。 ...

Key Takeaways MRK is focused on Winrevair's growth as Keytruda, its top revenue driver, faces patent expiration in 2028. Winrevair showed significant efficacy in PAH phase III trials, leading to early study stoppages. The FDA granted priority review to MRK's sBLA to update Winrevair's label, with a decision due on Oct. 25.Merck’s (MRK) blockbuster PD-L1 inhibitor, Keytruda, approved for several types of cancer indications, is the company's biggest revenue driver. The drug alone accounts for around 50% of ...

We're going to do a bit of a draft today. The five of us, we're going to pick five things each and it's going to be chaos and we're going to try to figure out what fictional tech do we want in our real lives. I'm going with the TARDIS from Doctor Who.Very good. Very good. My first pick is Capsules from Dragon Ball Z.I'm just going to take Jarvis from Iron Man. Oh, lost two already. Okay, just strategically, I think I need to grab the clueless closet.Surprised it took this long. I want kit. Okay, explain thr ...

They're on their way. They're looking at the parachutes. That's cool.You could see that from inside. What a cool shot of the booster and the capsule in one shot. That really just shows you how, you know, New Shepard is so reusable and, you know, just an incredible vehicle.And touchdown. Touchdown. ...

Beautiful landing site for the capsule. Oh yeah. Looks like it's going to be close to one of the roads, which is nice.Easy to get out there. There's a great shot actually of our crew recovery system. Yeah, they're on their way. They're looking at the parachutes.That's cool. You could see that from inside. What a cool shot of the booster and the capsule in one shot.That really just shows you how, you know, New Shepard is so reusable and, you know, just an incredible vehicle. And touchdown. Touchdown. ...